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Introduction: Offspring exposed to preeclampsia (PE) show an increased risk of cardiovascular disease in
adulthood. We hypothesize that this is mediated by a disturbed vascular development of the placenta,
umbilical cord and fetus. Therefore, we investigated associations between early-onset PE (EOPE), late-
onset PE (LOPE) and features of placental and newborn vascular health.
Methods: We performed a nested case-control study in The Rotterdam Periconceptional Cohort,
including 30 PE pregnancies (15 EOPE, 15 LOPE) and 218 control pregnancies (164 uncomplicated con-
trols, 54 complicated controls including 28 fetal growth restriction, 26 preterm birth) and assessed
macroscopic and histomorphometric outcomes of the placenta and umbilical cord.
Results: A signiﬁcant association was observed between PE and a smaller umbilical vein area and wall
thickness, independent of gestational age and birth weight. In EOPE we observed signiﬁcant associations
with a lower weight, length and width of the placenta, length of the umbilical cord, and thickness and
wall area of the umbilical vein and artery. These associations attenuated after gestational age and birth
weight adjustment. In LOPE a signiﬁcant association with a larger placental width and smaller umbilical
vein wall thickness was shown, independent of gestational age and birth weight.
Discussion: Our study suggests that PE is associated with a smaller umbilical cord vein area and wall
thickness, independent of gestational age and birth weight, which may serve as a proxy of disturbed
cardiovascular development in the newborn. Follow-up studies are needed to ultimately predict and
lower the risk of cardiovascular disease in offspring exposed to PE.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ce; PE, Preeclampsia; EOPE,
psia; FGR, Fetal growth re-
CI, Conﬁdence interval; IEL,
ing; EVG, Elastica Von Gieson
nd Gynaecology Erasmus MC,
lein 50, 3015 GE, Rotterdam,
teegers-Theunissen).
Ltd. This is an open access article u1. Introduction
In line with the developmental origins of health and disease
paradigm, epidemiological studies substantiated by animal studies
strongly suggest that adverse prenatal exposures increase the risk
of cardiovascular diseases in child- and adulthood [1,2]. Pre-
eclampsia (PE) occurs in approximately 2e8% of all pregnancies and
accounts for one of the major placental-related pregnancy com-
plications. PE is a complex disease characterised by increasednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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increased risks of fetal growth restriction (FGR) in 12% and preterm
birth (PTB) in 20% [3]. Evidence is accumulating that offspring
exposed to PE have enhanced risks of increased blood pressure and
body mass index in childhood and nearly a double risk of stroke in
adulthood [4e7]. Early-onset PE (EOPE) is often more severe than
late-onset PE (LOPE) and largely originates from poor ﬁrst trimester
placentation. LOPE seems to be exaggerated by predisposing car-
diovascular and metabolic risks for maternal endothelial dysfunc-
tion in the second half of pregnancy [4]. It was recently suggested
that LOPE may be associated with trophoblast dysfunction due to
villous overcrowding in term placentas, leading to diminished
intervillous perfusion and increased hypoxia [8]. Both PE pheno-
types show enhanced systemic inﬂammatory responses resulting
in exposure of vessels and tissues to excessive oxidative stress [9].
Impaired placentation is a result of inadequate invasion of the
maternal spiral arteries by the trophoblast, and has been suggested
to affect placental and fetal growth. A lower placental weight at
birth has been shown to predict the risk of hypertension in later life,
suggesting an association between placental morphological fea-
tures and offspring vascular health [10]. The umbilical-cord and
fetal vasculature share the same embryonic origin and are derived
from intra- and extra-embryonic mesodermal layers [11,12].
Therefore umbilical cord vessels are often used as a model for the
investigation of non-accessible fetal vessels to reﬂect newborn
vascular health [13e17]. These vessels are essential for prenatal
transport of oxygen, nutrient-rich and deoxygenated blood and
metabolic waste [11,12]. The development of the umbilical cord is
highly inﬂuenced by systemic and local haemodynamic conditions
of pregnancy, such as blood ﬂow, oxygen tension and oxidative
stress [18e20].
Here we hypothesize that a poor placental development
particularly in severe EOPE induces excessive inﬂammatory re-
sponses and changes in the intrauterine haemodynamics, contrib-
uting to the remodelling of the umbilical cord and fetal vasculature
and resulting in a vascular phenotype of the newborn at risk for
cardiovascular disease in later life. Therefore, the objective of our
study was to investigate associations between PE and the pheno-
types EOPE and LOPE, and placental and umbilical cord vessel
morphology as features of placental and newborn vascular health,
in which gestational age and birth weight are taken into account.
2. Methods
2.1. Study design
Between June 2011 and June 2013 mother-child pairs were
recruited before delivery and included in a nested case-control
study embedded in the Rotterdam Periconceptional Cohort (Pre-
dict Study), an ongoing prospective hospital-based cohort con-
ducted at the Erasmus MC, University Medical Centre Rotterdam,
The Netherlands [21]. We selected EOPE and LOPE as cases and
uncomplicated pregnancies as controls. In order to reduce con-
founding by FGR and iatrogenic PTB, we also included FGR and PTB
as complicated control groups.
2.2. Maternal characteristics
PE was deﬁned according to the International Society for the
Study of Hypertension in Pregnancy as gestational hypertension of
at least 140/90 mmHg accompanied by an urine protein/creatinine
ratio of 30 mg/mmol arising de novo after the 20th week of
gestation [22]. EOPE and LOPE were deﬁned as being diagnosed
before and after 34 weeks of gestation, respectively [23]. Uncom-
plicated control pregnancies were deﬁned as pregnancies withoutPE, gestational hypertension, FGR or PTB. FGR was deﬁned as an
estimated fetal weight below the 10th percentile for gestational age
based on ultrasound measurements performed between 20 and 38
weeks gestational age [24]. Birth weight percentiles were calcu-
lated using the reference curves of the Dutch Perinatal Registry to
validate birth weight <10th percentile [25]. PTB was deﬁned as a
spontaneous delivery between 22 and 37 weeks of gestation [26].
Maternal comorbidity was deﬁned by any concurrent presence of
cardiovascular-, endocrine-, metabolic-, auto-immune- and/or
renal disease. Women with HIV infection, aged <18 years, not able
to read and understand the Dutch language, multiple birth preg-
nancies or women with pregnancies complicated by fetal congen-
ital malformations were excluded.
Maternal and neonatal characteristics were obtained from
hospital medical records. All women gave written informed con-
sent before participation and parental informed consent was ob-
tained for the child. The research has been carried out in
accordance with the Declaration of Helsinki (2013) of the World
Medical Association.
2.3. Data collection
Macroscopic morphological outcomes including weight, length
and width of the placenta and length, diameter, number of vessels
and number of coils of the umbilical cord, were performed imme-
diately after delivery. The umbilical coiling index was calculated as
the total number of coils divided by the total length of the cord in
centimetres. After clamping of the umbilical cord, samples of two
centimetres for microscopic morphological examination were ob-
tained next to the clamping site within one hour after delivery and
immediately ﬁxed in a 4% formaldehyde solution for parafﬁn sec-
tions. All samples and measurements were obtained by trained
researchers according to protocol. Between 00:00 h and 07.00 h
and during weekends, placental measurements were not per-
formed due to logistic constraints.
2.4. Umbilical cord sample processing
Formalin-ﬁxed umbilical cord samples were cut in transversal
slices of four millimetres, perpendicular to the umbilical cord ves-
sels. The slices were dehydrated in graded ethanol series, cleaned in
xylene and embedded in parafﬁn. Parafﬁn samples were sectioned
at 4 micrometre. Sections were deparafﬁnised and hydrated, before
Haematoxylin/eosin (HE) staining and Elastica Von Gieson (EVG)
staining was performed. Sections were digitally scanned using a
digital slide scanner (NanoZoomer 2.0-HT, C9600-13, Hamamatsu
Photonics, Japan) and analysed using the software NDP.view2,
U12388-01 (Hamamatsu Photonics, Japan), IMAGE J version 2.0
(National Institutes of Health, US) and KS400 version 3.0 (Carl Zeiss
Vision GmbH, Aalen, Germany).
The following parameters of the umbilical cord were measured
in digitised HE stained sections; umbilical cord area, Wharton jelly
area, vessel area, vessel lumen area and vessel wall thickness. Every
individual area was measured manually with Image J [27]. Vessel
wall thickness was measured manually in NDP viewer, as the mean
of the smallest and largest wall diameter. Artery wall measure-
ments were performed for both the internal and external muscular
layer. EVG stained sections were used for the measurement of the
percentage of elastin content in the wall of the umbilical artery and
umbilical vein and internal elastic lamina (IEL) of the umbilical vein
with KS400. The area of elastic ﬁbres in the vessels was digitally
marked and divided by the total vessel area to calculate the per-
centage of elastin content in the vein and in one artery separately.
All measurements were performed blinded by one researcher.
Only sections without artefacts were used for analysis. Accuracy of
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enced pathologist at the Erasmus MC, University Medical Centre in
Rotterdam.2.5. Statistical analysis
For normal distributed maternal and neonatal characteristics
and outcomes of the umbilical cord and placenta Analysis of Vari-
ance (ANOVA) was applied to assess overall differences between
the groups, followed by the post hoc Dunnett t-test for pairwise
comparisons between EOPE, LOPE and uncomplicated and
complicated control groups. Kruskall-Wallis was applied to skewed
variables, followed by pairwise Mann-Whitney tests for posthoc
comparisons.
In the comparisons between PE and the total control group,
multivariable linear regression analysis with adjustment for
gestational age and birth weight was applied. We additionally
applied the multivariable linear regression model to compare EOPE
and LOPE with the total control group.
Differences were considered statistically signiﬁcant at p < 0.05.
All analyses were performed with Statistical Package for Social
Sciences (SPSS, version 21.0, SPSS Inc, Chicago, IL, USA).3. Results
298 women met the inclusion criteria and after exclusion of 50
pregnancies because of missing umbilical cord samples or macro-
scopic outcomes, 248 pregnancies remained for further analysis
(Fig. 1). PE cases comprised 15 EOPE and 15 LOPE, and controls
included 164 uncomplicated and 54 complicated pregnancies (28
FGR, 26 PTB). Microscopic outcomes were assessed in all EOPE, 14
LOPE, a random selection of 24 uncomplicated- and in 52 compli-
cated control pregnancies.
Maternal and neonatal characteristics are depicted in Table 1.
Except for the case speciﬁc parameters, such as blood pressure,
proteinuria, gestational age and birth weight, we observed a higher
frequency of nulliparous women in EOPE (80.0%) and LOPE (86.7%)
versus uncomplicated controls (40.9%) and PTB (46.2%, overallEligible pat
n=298
Final study pop
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n=15
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Control
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Total con
EOPE
n=15
Fig. 1. Flowchart of tp < 0.001). The frequency of caesarean section was higher in EOPE
(80%) compared to LOPE and (un)complicated controls (23.1e37.5%,
overall p¼ 0.004). In EOPE, one pregnancy was complicated by FGR
(6.7%) versus two in LOPE (13.3%, p ¼ 1.000) and all pregnancies
were complicated by PTB (100%) versus two in LOPE (13.3%,
p < 0.001).
Table 2 depicts the results of the multivariable linear regression
analyses with gestational age and birth weight adjustments for the
associations between themacroscopic morphological placental and
umbilical cord outcomes and total PE, EOPE and LOPE versus the
total control group. A negative association with placental weight,
length and width and umbilical cord length was observed in total
PE and EOPE, which attenuated after adjustment for birth weight
and gestational age. LOPE was only positively associated with
placental width, which remained statistically signiﬁcant after
adjustment for birth weight and gestational age (p ¼ 0.009).
Macroscopic morphological outcomes of the placenta and um-
bilical cord are also depicted in Supplemental table 1. In EOPE we
observed negative associations with placental weight, length and
width and umbilical cord length versus (un)complicated controls
(overall p<0.001). In LOPE Dunnett t-testing revealed a signiﬁcantly
higher placental weight compared to FGR, and a higher placental
width compared to FGR and PTB complicated controls.
The multivariable linear regression analyses for the microscopic
umbilical cord outcomes are depicted in Table 3. Since there were
no signiﬁcant differences between the two individual artery mea-
surements, the mean of both measurements was used for further
analysis. In PE we revealed a negative association with umbilical
cord length, total vessel area, vein area and wall thickness, total
artery area, outer artery wall area and artery wall thickness (all
p < 0.05). After adjustment for gestational age and birth weight, PE
remained inversely associated with the vein area (b 1.05, 95% CI
-2.05, 0.04, p ¼ 0.041) and vein wall thickness (b 0.15, 95% CI
-0.26, 0.04, p ¼ 0.006). EOPE was negatively associated with total
umbilical cord vessel area, vein area, wall thickness and artery areas
and wall thickness, which attenuated after adjustment for gesta-
tional age and birth weight. A negative association was observed
between LOPE and vein wall thickness, only after adjustment forients
Missing umbilical cord samples or macroscopic 
measurements
n=50
ulation
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Table 1
Maternal and neonatal characteristics.
Maternal characteristics Cases Uncomplicated Complicated controls Overall
EOPE LOPE Controls Normotensive FGR Normotensive PTB
(n ¼ 15) (n ¼ 15) (n ¼ 164) (n ¼ 28) (n ¼ 26) p-value
Age (years) 30.4 (5.2) 33.3 (4.7) 32.3 (4.9) 29.7 (5.9) 30.9 (5.1) 0.051
Nulliparous, n (%) 12 (80.0) 13 (86.7) 67*,y (40.9) 17 (60.7) 12*,y (46.2) <0.001
Geographical origin, n (%) 0.172
Western 13 (86.7) 8 (53.3) 130 (79.8) 18 (64.3) 22 (84.6)
Non-Western 2 (13.3) 7 (46.7) 33 (20.2) 10 (35.7) 4 (15.4)
Preconception BMIz (kg/m2) 24.1 (9.1) 24.2 (4.3) 24.1 (7.1) 22.5 (6.2) 23.9 (6.4) 0.620
Smoking in pregnancy (yes), n (%) 2 (15.4) 0 (0.0) 9 (5.7) 2 (7.7) 2 (8.7) 0.549
Co-morbidity (yes), n (%) 1 (6.7) 7 (46.7) 49 (30.1) 7 (25.0) 5 (19.2) 0.115
Neonatal characteristics
Gender (male), n (%) 5 (33.3) 6 (40.0) 85 (51.8) 15 (53.6) 13 (50.0) 0.622
Gestational age at birthz (weeks) 30.7 (3.4) 37.4* (1.9) 39.6*,y (1.7) 38.9* (2.6) 35.1*,y (6.6) <0.001
Birth weightz (grams) 1185 (435) 3200* (1250) 3560*,y (565) 2628*,y (593) 2568*,y (1674) <0.001
Birth weight <10th percentile, n (%) 1 (6.7) 2 (13.3) 0y (0.0) 28*,y (100.0) 0 (0.0) <0.001
Data are presented as mean (standard deviation) with corresponding ANOVA testing to examine overall differences between the groups, followed by the post hoc Dunnett t-
test for pairwise comparisons between EOPE, LOPE and the uncomplicated and complicated control groups.
Data are presented as number (%) with corresponding Chi2/Fischer's exact testing.
zSkewed data are presented as median (interquartile range) with corresponding Kruskall-Wallis testing and posthoc Mann-Whitney testing.
*p < 0.05 versus EOPE pregnancies.
yp < 0.05 versus LOPE pregnancies. ANOVA analysis of variance; BP blood pressure; BMI body mass index; EOPE early onset preeclampsia; LOPE late onset preeclampsia; FGR
fetal growth restriction; PTB preterm birth.
Table 2
Multivariable linear regression analysis of the macroscopic morphology of the placenta and umbilical cord in EOPE and LOPE versus the total control group.
PE (n ¼ 30) EOPE (n ¼ 15) LOPE (n ¼ 15)
Crude b Adjusted b (GA þ BW) Crude b Adjusted b (GA þ BW) Crude b Adjusted b (GA þ BW)
Macroscopy of the placenta
Weight (gr) 148.0 (236, 60)* 34.0 (31, 98) 300.1 (408.7,191.5)* 6.7 (86.6, 100.1) 41.9 (81.7, 165.5) 55.5 (28.8, 139.8)
Length (cm) 2.38 (3.84, 0.92)* 0.52 (1.99, 0.95) 3.9 (5.8, 2.0)* 0.2 (2.4, 2.1) 0.7 (2.7, 1.3) 0.8 (2.6, 1.0)
Width (cm) 1.51 (2.85, 0.18)* 0.99 (0.22, 2.21) 4.8 (6.4, 3.2)* 0.8 (2.6, 1.0) 2.1 (0.3, 3.8)* 2.0 (0.5, 3.6)*
Macroscopy of the umbilical cord
Length (cm) 6.92 (11.75, 2.08)* 0.33 (5.50, 4.84) 15.6 (22.1, 9.2)* 5.2 (13.4, 3.0) 1.8 (4.7, 8.4) 2.4 (4.0, 8.7)
Diameter (mm) 0.69 (0.71, 2.09) 1.02 (0.54, 2.58) 0.2 (1.8, 2.1) 1.1 (1.4, 3.6) 1.2 (0.7, 3.1) 1.1 (0.7, 3.0)
Coiling index (coils/cm) 0.01 (0.04, 0.03) 0.02 (0.06, 0.02) 0.0 (0.0, 0.1) 0.0 (0.0, 0.1) 0.0 (0.1, 0.0) 0.0 (0.1, 0.0)
Data are presented as b (95% Conﬁdence Interval) with corresponding multivariate linear regression analysis of both EOPE (on the left) and LOPE (on the right) versus the total
control group (n ¼ 218), crude and with adjustment for gestational age and birth weight. The regression coefﬁcient (b) indicates the increase or decrease () change per unit.
*p < 0.05. GA gestational age; BW birth weight; PE preeclampsia; EOPE early-onset preeclampsia; LOPE late-onset preeclampsia. Missings are depicted in Supplemental table 1.
Table 3
Multivariable linear regression analysis of the microscopic morphology of the umbilical cord in EOPE and LOPE versus the total control group.
PE (n ¼ 29) EOPE (n ¼ 15) LOPE (n ¼ 14)
Crude b Adjusted b (GA þ BW) Crude b Adjusted b (GA þ BW) Crude b Adjusted b (GA þ BW)
Total cord area (mm2) 8.92 (21.39, 3.55) 5.17 (17.77, 7.43) 12.1 (28.7, 4.5) 6.9 (12.5, 26.3) 5.8 (22.8, 11.3) 11.1 (27.5, 5.3)
Wharton jelly area (mm2) 2.53 (16.00, 10.93) 1.41 (15.09, 12.27) 3.7 (22.1, 14.7) 12.4 (9.4, 34.2) 1.5 (19.2, 16.1) 7.3 (24.1, 9.5)
Total vessel area (mm2) 2.01 (3.49, 0.52)* 1.25 (2.64, 0.14) 3.3 (5.3, 1.2)* 0.3 (2.7, 2.0) 0.9 (2.8, 1.1) 1.6 (3.4, 0.2)
Total lumen area (mm2) 0.10 (0.50, 0.31) 0.32 (0.46, 0.39) 0.4 (1.0, 0.1) 0.3 (1.0, 0.4) 0.2 (0.3, 0.7) 0.1 (0.4, 0.7)
Umbilical vein
Total area (mm2) 1.67 (2.71, 0.63)* 1.05 (2.05, 00.04)* 2.6 (4.0, 1.2)* 0.8 (2.4, 0.9) 0.7 (2.1, 0.7) 1.1 (2.5, 0.2)
Wall thickness (mm) 0.19 (0.29. 0.09)* 0.15 (0.26, 0.04)* 0.3 (0.4, 0.1)* 0.1 (0.3, 0.0) 0.1 (0.3, 0.0) 0.1 (0.3, 0.0)*
Lumen area (mm2) 0.11 (0.44, 0.23) 0.04 (0.30, 0.37) 0.4 (0.8, 0.0) 0.1 (0.6, 0.5) 0.2 (0.3, 0.7) 0.1 (0.3, 0.6)
Elastin content % 0.73 (1.75, 0.29) 0.26 (1.31, 0.78) 1.2 (2.6, 0.1) 0.4 (1.2, 2.0) 0.2 (1.6, 1.2) 0.5 (1.9, 0.9)
Umbilical artery
Total area (mm2) 0.46 (0.88, 0.05)* 0.23 (0.64, 0.18) 0.7 (1.3, 0.2)* 0.0 (0.7, 0.6) 0.2 (0.8, 0.4) 0.4 (0.9, 0.2)
External wall layer area (mm2) 0.41 (0.71, 0.11)* 0.24 (0.54, 0.06) 0.6 (1.0, 0.2)* 0.2 (0.6, 0.3) 0.2 (0.6, 0.2) 0.3 (0.7, 0.1)
Internal wall layer area (mm2) 0.14 (0.29, 0.02) 0.05 (0.20, 0.10) 0.2 (0.4, 0.0)* 0.1 (0.2 0.3) 0.1 (0.3, 0.2) 0.1 (0.3, 0.10)
Wall thickness (mm) 0.07 (0.13, 0.00)* 0.03 (0.09, 0.03) 0.1 (0.2, 0.0)* 0.0 (0.1, 0.1) 0.0 (0.1, 0.0) 0.1 (0.1, 0.0)
Lumen area (mm2) 0.05 (0.03, 0.13) 0.03 (0.57, 0.12) 0.1 (0.0, 0.2) 0.1 (0.1, 0.2) 0.0 (0.1, 0.1) 0.0 (0.1, 0.1)
Elastin content % 0.06 (0.90, 0.77) 0.13 (0.74, 1.00) 0.1 (1.3, 1.0) 0.4 (1.0, 1.8) 0.0 (1.0, 1.1) 0.0 (1.1, 1.1)
Data are presented as b (95% Conﬁdence Interval) with corresponding multivariate linear regression analysis of both EOPE (on the left) and LOPE (on the right) versus the total
control group (n ¼ 76), crude and with adjustment for gestational age and birth weight. The regression coefﬁcient (b) indicates the increase or decrease () change per unit.
*p < 0.05. GA gestational age; BW birth weight; PE preeclampsia; EOPE early-onset preeclampsia; LOPE late-onset preeclampsia. Missings are depicted in Supplemental table 2.
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Fig. 2. Microscopic morphological outcomes of the umbilical cord.
Microscopic morphological outcomes of the umbilical cord are presented as mean (þ/ standard deviation) with corresponding ANOVA testing to examine overall differences
between the groups, followed by the post hoc Dunnett t-test for pairwise comparisons of EOPE and LOPE with the (un)complicated control groups. z Skewed data are analysed by
Kruskall-Wallis testing.
*p < 0.05 versus EOPE pregnancies. yp < 0.05 versus LOPE pregnancies. ANOVA analysis of variance; EOPE early onset preeclampsia; LOPE late onset preeclampsia; FGR fetal growth
restriction; PTB preterm birth.
Fig. 3. Microscopic transversal sections of the umbilical cord in an uncomplicated control.(A) and EOPE (B).
Legend: Umbilical cord parafﬁn section with Haematoxylin Eosin staining. Veins consist of a single layer circular smooth muscle cells and an internal elastic lamina (IEL). The
umbilical arteries have a double-layered muscular wall divided in an internal layer of longitudinal smooth muscle cells and an external layer of crossing spiralled smooth muscle
cells. Umbilical arteries do not contain an IEL.
A and B. Umbilical cord transversal section of an uncomplicated control (A) and EOPE (B) with a smaller vein area versus (un)complicated pregnancies.
C and D. Umbilical cord transversal parafﬁn sections with Elastic Van Gieson staining in an uncomplicated control (C) and EOPE (D) with a lower total vein elastin content versus
uncomplicated pregnancies (x5). W Wharton jelly; V vein; A artery; i internal muscular layer; e external muscular layer; IEL internal elastic lamina.
E.M. Herzog et al. / Placenta 49 (2017) 72e7976gestational age and birth weight.
In Figs. 2 and 3 and Supplemental table 2 the microscopic
morphological outcomes of the umbilical cord are depicted per
group. In EOPE we observed smaller total umbilical cord areas, vein
area, wall thickness, external artery wall area and vein elastin
content compared to uncomplicated controls. In EOPE vein total
area and vein wall thickness were also signiﬁcantly smaller
compared to FGR and PTB (overall p ¼ 0.001 and p ¼ 0.004
respectively). In LOPE we only observed a smaller Wharton jelly
area versus uncomplicated controls (p ¼ 0.030).4. Discussion
4.1. Main ﬁndings
This study shows a negative association between the umbilical
vein area and vein wall thickness in the total group of PE preg-
nancies, independent of gestational age and birth weight. In EOPE,
the negative associations with placental weight, length and width
and umbilical cord length, vein and artery wall area and wall
thickness are largely explained by a shorter gestational age and
lower birth weight. This is in contrast to LOPE showing a positive
E.M. Herzog et al. / Placenta 49 (2017) 72e79 77association with placental width and a negative association with
umbilical vein wall thickness independent of gestational age and
birth weight.
4.2. Strengths and limitations
Strengths of our study are that we established different associ-
ations between EOPE and LOPE and microscopic morphological
outcomes in umbilical cord vessels and independent of FGR and
PTB. The digital qualitative elastin measurement-technique is novel
and accurate and seems feasible for future examinations.
4.3. Interpretation
The different associations observed in EOPE and LOPE with
placental and umbilical cord morphology can partly be explained
by a shorter gestational age and lower birth weight in the more
severe EOPE phenotype. In addition, the positive association be-
tween LOPE and placental width is even opposite to the association
with EOPE, as observed by others [28]. Kajantie et al. described an
association between a smaller placental width and the risk of PE
severity, which is in line with our observation in EOPE suggesting
that placental width is a marker of placental development [10]. The
discrepancy of placental measurements in EOPE and LOPE may be
explained by the concept of initial poor and restricted placental
development in EOPE versus microvillous overcrowding in term
placentas without prior pathology in LOPE [8].
The association of an approximately 2-fold smaller vein area and
approximately 1.5-fold smaller vein wall thickness in EOPE
compared to the total control group was much stronger than in
LOPE, but appeared only independent of gestational age and birth
weight in LOPE. This may be due to the exposure to maternal car-
diovascular and metabolic risk factors associated with LOPE (47% in
LOPE versus 7% in EOPE pregnancies). However, in the total PE
group we also demonstrated that the EOPE and LOPE subgroups
may in fact be underpowered, by revealing a strong signiﬁcant
association with a smaller vein area and wall thickness in PE, in-
dependent of gestational age and birth weight. Moreover, the low
rate of FGR cases within the EOPE pregnancies indicates that a
relatively small number of pregnancies complicated with severe
placental dysfunction leading to FGR were included, which cannot
exclude that the observed association is underestimated.
We do believe that the signiﬁcantly smaller vein wall thickness
is related to the adverse inﬂuences originating from PE itself and
possibly the additional complications of PTB and FGR. Both gesta-
tional age and birthweight are highly related to the severity and
moment of onset of PE, suggesting that the most evident ﬁndings
are appearing in the most severe EOPE cases, who suffered from
excessive oxidative stress from the beginning of pregnancy. PTB
and FGR have indeed been associated with alterations of cardio-
vascular risk factors in offspring [29,30]. However, as suggested by
our data and that of others, the intrauterine PE environment seems
to be unique and exacerbates or acts in synergy with any risks
inferred by PTB or FGR [31]. During normal fetal development, the
morphology of the vessel walls changes due to a thickening of the
elastic lamellae of the media [32]. PE however deranges the hae-
modynamic characteristics of the materno-fetal circulation with
ﬂuctuations in shear stress, which affects the fetal vascular devel-
opment [33,34]. It has been shown that umbilical perfusion and
elastin content of the umbilical veins are decreased in neonates
born after PE [13,16]. Additionally, episodes of placental hypoxia or
reperfusion result in excessive oxidative stress and the production
of inﬂammatory cytokines in both maternal and fetal circulation
[35]. A disbalance between angiogenic factors and pro-
inﬂammatory chemokines is associated with maternal endothelialcell dysfunction as pregnancy advances with possible conse-
quences for the structure and content of the vessel walls [4]. In PE
pregnancies a reduced prostacyclin production in endothelial cells
of the umbilical cord vessels resulting in decreased placental
perfusion and umbilical cord blood ﬂow has been observed [36].
This substantiates our ﬁnding of the smaller umbilical cord vein
wall thickness and tendency of decreased elastin content being
related to the haemodynamic ﬂuctuations and excessive oxidative
stress.
An overexpression of type III and down regulation of type I
collagen has been described in umbilical cord veins, arteries and
Wharton jelly of neonates exposed to PE, which decreases solubility
(water-binding capacity) and may explain the smaller vessel wall
thickness and also the decreased elastin content of the umbilical
vein walls [15,16].
Our ﬁndings are consistent with Inan et al., who reported a
signiﬁcant reduction in the umbilical vein and artery wall areas of
70 neonates exposed to PE [14]. In contrast, two smaller studies
reported an increased umbilical artery wall thickness, which may
be due to differences in the deﬁnition of PE and umbilical cord
sampling methods (at the placental side instead of next to the
umbilical cord clamping site) and sample sizes [13,17].
5. Conclusion
Our study suggests that PE is associated with a smaller umbilical
cord vein area and wall thickness, independent of gestational age
and birth weight, which may be considered as a proxy for early
features of disturbed cardiovascular development in the newborn.
Periconceptional follow-up studies are needed to ultimately
predict the risk of cardiovascular disease in offspring exposed to PE
which may create opportunities for early prediction, prevention
and treatment in the future.
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